Previous Article | Next Article 
Journal of Virology, March 1999, p. 1818-1827, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genetic Analysis of a Unique Human Immunodeficiency
Virus Type 1 (HIV-1) with a Primer Binding Site Complementary to
tRNAMet Supports a Role for U5-PBS Stem-Loop RNA Structures
in Initiation of HIV-1 Reverse Transcription
Sang-Moo
Kang and
Casey D.
Morrow*
Department of Microbiology, University of
Alabama at Birmingham, Birmingham, Alabama 35294
Received 16 July 1998/Accepted 24 November 1998
 |
ABSTRACT |
Human immunodeficiency virus type 1 (HIV-1) exclusively uses
tRNA3Lys to initiate reverse transcription. A novel
HIV-1 mutant which stably utilizes tRNAMet rather than
tRNA3Lys as a primer was previously identified
[HXB2(Met-AC] (S.-M. Kang, Z. Zhang, and C. D. Morrow, J. Virol. 71:207-217, 1997). Comparison of RNA secondary structures of
the unique sequence (U5)-primer binding site (PBS) viral RNA genome
alone or complexed with tRNAMet of HXB2(Met-AC) revealed
structural motifs in common with the U5-PBS of the wild-type virus. In
the current study, mutations were constructed to alter the U5-PBS
structure and disrupt the U5-PBS-tRNAMet interaction of the
virus derived from HXB2(Met-AC). All of the mutant viruses were
infectious following transfection and coculture with SupT1 cells.
Analysis of the initiation of reverse transcription revealed that some
of the mutants were impaired compared to HXB2(Met-AC). The genetic
stability of the PBS from each virus was determined following in vitro
culture. Two mutant proviral constructs, one predicted to completely
disrupt the stem-loop structure in U5 and the other predicted to
destabilize contact regions of U5 with tRNAMet, reverted
back to contain a PBS complementary to tRNA3Lys. All
other mutants maintained a PBS complementary to tRNAMet
after in vitro culture, although all contained multiple nucleotide substitutions within the U5-PBS from the starting proviral clones. Most
interestingly, a viral mutant containing a 32-nucleotide deletion
between nucleotides 142 and 173, encompassing regions in U5 which
interact with tRNAMet, maintained a PBS complementary to
tRNAMet following in vitro culture. All of the proviral
clones recovered from this mutant, however, contained an additional
19-nucleotide insertion in U5. RNA modeling of the U5-PBS from this
mutant demonstrated that the additional mutations present in U5
following culture restored RNA structures similar to those modeled from
HXB2(Met-AC). These results provide strong genetic evidence that
multiple sequence and structural elements in U5 in addition to the PBS
are involved in the interaction with the tRNA used for initiation of
reverse transcription.
 |
INTRODUCTION |
A hallmark of the retrovirus life
cycle is the process by which the single-stranded viral RNA genome is
converted into a double-stranded DNA (1, 25). This process,
called reverse transcription, uses a virus-encoded enzyme, reverse
transcriptase (RT), and a cellular tRNA primer. The tRNA is bound to a
site on the viral RNA genome, designated the primer binding site (PBS),
which is complementary to the 3'-terminal 18 nucleotides of the tRNA
(4, 18). The PBS is located downstream of the 5' direct
repeat (R) and unique sequence (U5) in the viral RNA genome.
The tRNA primer used for initiation of reverse transcription is
different for individual retrovirus groups. For example,
tRNA3Lys is used by lentiviruses such as HIV-1 (human
immunodeficiency virus type 1) or simian immunodeficiency virus, while
tRNA1,2Lys is used by Mason-Pfizer monkey virus, visna
virus, and spumavirus; murine leukemia virus uses tRNAPro,
while avian sarcoma virus and avian leukosis virus use
tRNATrp (15, 16). Why retroviruses use different
but specific tRNA primers to initiate reverse transcription is unknown.
The exclusive use of specific tRNAs to initiate reverse transcription
cannot be explained by incorporation into the virion particle, since a
subset of cellular tRNAs, in addition to the specific tRNA used for
initiation, are encapsidated. For example, HIV-1 virions contain a
subset of cellular tRNAs comprised of 30% tRNA3Lys,
60% tRNA1,2Lys, and 10% minor tRNAs (7,
29). Recent studies have demonstrated that the composition of the
tRNA species within the virion does not necessarily dictate which tRNA
will be used to initiate reverse transcription. HIV-1 with genetically
engineered PBS complementary to alternative tRNAs could use a wide
variety of tRNAs for initiation of reverse transcription. The PBSs of
these viruses were not stable and reverted to the wild-type PBS,
complementary to tRNA3Lys, after a few passages of in
vitro culture (3, 11, 28). Based on these results, it was
suggested that factors other than the PBS sequence specify the
preferential usage of the wild-type primer for the initiation of
retroviral reverse transcription.
Recent studies have provided evidence of additional interactions
between the 5' region of the retroviral genome and the primer tRNA.
Chemical and enzymatic footprinting of the HIV-1 genomic RNA and
tRNA3Lys has found additional sites in U5 involved in
intermolecular contacts. In one of these interactions, the anticodon
loop of tRNA3Lys binds with an A-rich loop located 12 to 17 nucleotides upstream of the PBS (5, 6, 14). Genetic
evidence for a role of this A-rich loop region in interacting with
primer tRNA was provided by demonstrating that if both the PBS and
A-rich loop in U5 are mutated so as to be complementary to the
3'-terminal nucleotides and anticodon loop of tRNAHis
(27) or tRNAMet (9), the resulting
viruses would stably maintain a corresponding PBS complementary to
tRNAHis or tRNAMet, respectively, after
extended in vitro culture. In a follow-up study, we found that the tRNA
composition in the virions from viruses which stably utilize
tRNAHis to initiate reverse transcription was not changed
compared to that of the wild-type virus (29). The complexity
of the U5-PBS interaction with tRNA is highlighted by the fact that not
all combinations of PBS and anticodon complementary sequence in U5 (A-loop region) produce viruses which can stably maintain a PBS complementary to alternative tRNAs (8).
The development of infectious HIV-1 which stably maintain a PBS
complementary to an alternative tRNA provides a unique opportunity to
genetically test the importance of the U5-PBS in the selection of the
tRNA used for initiation of reverse transcription. We have previously
reported on the characterization of an HIV-1 which uses
tRNAMet to initiate reverse transcription (9).
In contrast to our other HIV-1, which utilize an alternative tRNA to
initiate reverse transcription, the virus which uses
tRNAMet occurred spontaneously in in vitro cultures.
Follow-up studies established that this virus was stable if a region
within U5 was engineered to contain a sequence complementary to the
anticodon loop of tRNAMet. In the current study, we found
that modeling of the U5-PBS region of this virus without and with bound
tRNAMet revealed RNA structures with striking similarities
to the wild-type virus (see Fig. 1). To determine a biological
significance for these RNA structures, we constructed proviral clones
which contain mutations designed specifically to disrupt the stem-loop
structures in U5 of this virus. The capacity of these mutant viruses to
use a tRNAMet as a primer in an in vitro endogenous reverse
transcription assay and maintain the PBS complementary to
tRNAMet following in vitro culture was also determined. Our
studies demonstrate that mutations upstream of the A-loop region in U5
affect reverse transcription and utilization of the tRNAMet
primer. Modeling of the RNA genomes containing the nucleotide substitutions which arise in viruses following in vitro culture supports the conclusion that U5-PBS RNA structure plays an important role in the selection of the tRNA and subsequent initiation of reverse transcription.
 |
MATERIALS AND METHODS |
Construction of vectors with mutant proviral genomes.
The
HXB2 molecular clone of HIV-1 was used to construct the mutant HIV-1
proviral genomes (19). We previously reported the construction of pHXB2(Met-AC) with a substitution of the nucleotide sequence TGTGAGACTG (nucleotides 167 to 176) in U5 and a PBS
complementary to tRNAMet, which resulted in the virus
stably maintaining a PBS complementary to tRNAMet
(9). From a virus culture derived from pHXB2(Met-AC), a U5 PBS region was PCR amplified from provided DNA with three additional point mutations in U5 (145C to T, 171G to A,
and 201G to A); this U5-PBS was isolated and used to
construct HXB2(Met-AC). A BglII and BssHII DNA
fragment (nucleotides 20 to 255) from the clone was first purified from
a 1.2% agarose gel and cloned into shuttle vector pUC119(PBS), which
contains an HpaI-to-PstI DNA fragment including
the 5' long terminal repeat, PBS, and leader region of the
gag gene from HXB2. The resulting clone was named pUC119(Met-AC). All other mutant constructs were created by introducing mutations in the U5 region of the pUC119(Met-AC) shuttle vector by
using two consecutive PCR mutageneses (23). The first PCR was done to generate megaprimers containing mutant sequences by using a
primer in the U3 region of the 5' long terminal repeat (5'TTGACAGCCGCCTAGC3' [nucleotides 8895 to 8910]) and a
mutagenic oligonucleotide. The mutations which were constructed are
depicted in Fig. 1 and
2. The oligonucleotides used for
construction of the mutants are as follows: Met-AC(157-161),
5'-CTCACAACACTCTGACAAAGGGTCTGAAG-3'; Met-AC(162-164),
5'-AGTCTCACAACTGAGACTAAAAGGGTC-3'; Met-AC(157-166), 5'-GCTACAGTCTCACAGACAAAAGCGAAAGGGTCTGAAGGA-3';
Met-AC(153-161), 5'-GTCTCACAACACTTGTGAGACTGGTCTGAAGGATCTC-3';
Met-AC(161-163), 5'-AGTCTCACAACAGACACTAAAAGGGTC-3';
Met-AC(143-146), 5'-ACTAAAAGGGTCTGTTCCATCTCTAGTTACC-3'; Met-AC(143-146,161-163),
5'-AGTCTCACAACAGACACTAAAAGGGTCTGTTCCATCTCTAGTTACCA-3'; and
Met-AC(
142-173),
5'-CCACTGCTAGAGTCTCTAGTTACCAGAGTCAC-3'.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
RNA modeling of wild-type and mutant viral U5-PBS and
U5-PBS/tRNA. (A) The viral RNA sequence of nucleotides 1 to 230 encompassing the R-U5-PBS from the wild-type (HXB2) and mutant
HXB2(Met-AC) viruses was used to predict the RNA secondary structures
by using MFold (33). Only structures from nucleotides 126 to
224 are shown; the original clone of HXB2(Met-AC) has a two-nucleotide
deletion downstream of the PBS. The ACN sequences are marked. The
regions targeted for mutations are designated a to d and underlined.
The designation +1 indicates the first nucleotide of the RNA template
for negative-strand DNA synthesis. Nucleotides 183 to 200 are the PBS
sequence. (B) RNA structure of U5-PBS/tRNA based on a model proposed by
Isel et al. (5). Viral RNA sequences are shown in capital
letters and tRNA sequences (only the sequences interacting with viral
RNA are displayed) are in boldface lowercase letters. Region I depicts
the PBS-tRNA interaction. Region II is the A-loop region in U5
complementary to the anticodon loop of tRNA. Region III is
complementary to the 3' anticodon stem of tRNA. Region IV is
complementary to the variable loop of tRNA.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
Expanded view of the 5' region of the HIV-1(HXB2) RNA
genome and nucleotide sequences of the U5-PBS region in wild-type and
mutant proviruses. (A) Schematic location of the R-U5-PBS region in
HIV-1 genomic RNA. R is the direct repeat sequence at the 5' and 3'
ends of the viral RNA genome. (B) Nucleotide sequences of wild-type
(HXB2) and mutant proviruses constructed from HXB2(Met-AC). a, b, c,
and d are regions involved in the stem-loop structure in U5 as
described in Fig. 1A. I, II, III, and IV are regions of viral RNA
positioned to interact with the tRNA primer as described in Fig. 1B.
Regions targeted for mutation are aligned and boxed along with the ACN
sequence (II) and the PBS (I). Asterisks indicate partial disruption of
the marked region, and dots indicate deletion. Designations:
Met-AC(157-161), HXB2(Met-AC(157-161)); Met-AC(161-164),
HXB2(Met-AC(161-164)); Met-AC(157-166), HXB2(Met-AC(157-166));
Met-AC(153-161), HXB2(Met-AC(153-161)); Met-AC(161-163),
HXB2(Met-AC(161-163)); Met-AC(143-146), HXB2(Met-AC(143-146));
Met-AC(143-146, 161-163), HXB2(Met-AC(143-146, 161-163));
Met-AC( 142-173), HXB2(Met-AC( 142-173)).
|
|
Megaprimers containing the mutant sequences were used in the second PCR
together with a primer with a
BssHII site downstream
of the
PBS (5'-GCGCGCTTCAGCAAGCCG-3' [nucleotides 262 to 245])
to
generate restriction enzyme sites for cloning into pUC119(PBS).
The
resulting mutagenic DNA fragments were digested with
BglII
and
BssHII (nucleotides 20 to 262) and cloned into
pUC119(PBS),
creating the corresponding mutant shuttle vectors. An
868-bp fragment
of
HpaI and
BssHII from each of
the pUC119 plasmid constructs
containing the mutant sequences was
subcloned between the
HpaI
and
BssHII sites of
HXB2. All pUC119 constructs and the resulting
HXB2 mutant proviral
plasmids were verified by DNA sequencing
to ensure the identity of the
mutated sequence (
22).
Tissue culture and DNA transfections.
293T and COS-1 cells
were maintained in Dulbecco's modified Eagle's medium supplemented
with 10% fetal calf serum and 1% penicillin-streptomycin at 37°C
and 5% CO2. SupT1 cells were grown in RPMI 1640 medium containing 15% fetal calf serum and 1% penicillin-streptomycin at
37°C and 5% CO2. 293T cells were grown overnight to
about 70% confluence in a six-well plate and transfected with 10 µg
of HXB2 proviral DNA constructs using the Ca-PO4 method
(Stratagene protocol). After overnight incubation at 37°C, the
supernatant of transfected 293T cells was removed and fresh medium was
added. The supernatant was collected at 3 days posttransfection and
filtered through a 0.45-µm-pore-size syringe filter (Nalgene). The
levels of p24 capsid antigen were determined from three independent
transfections by using an enzyme-linked immunosorbent assay (ELISA;
Coulter Laboratories). COS-1 cells (at 60% confluence) were
transfected with 5 µg of wild-type or mutant proviral plasmid DNA by
using DEAE-dextran as previously described (20).
Endogenous reverse transcription followed by PCR.
The
endogenous reverse transcription was performed by using virus particles
supplied with nucleotide substrates as described elsewhere
(17). Supernatants from 293T cells transfected with proviral
DNAs were treated with RNase-free DNase I (Boehringer Mannheim) at a
final concentration of 20 U/ml for 1 h at 37°C in the presence
of 10 mM MgCl2. Virus particles from transfected supernatants were collected by centrifugation at 27,000 rpm for 2 h in an SW28 rotor at 4°C. The pellet was resuspended in 200 µl of
ice-cold TEN buffer (100 mM NaCl, 10 mM Tris-HCl, pH 8.0), and aliquots
of virus were kept at
70°C. For endogenous reverse transcription,
aliquots of a virus suspension (equivalent to 6 ng of p24) were
incubated in 60 µl of the reaction mixture (0.01% Triton X-100, 50 mM NaCl, 50 mM Tris-HCl [pH 8.0], 10 mM dithiothreitol, 5 mM
MgCl2, 200 µM each dATP, dGTP, dCTP, and dTTP) for 0 min, 20 min, 1 h, and 2 h at 37°C. Reactions were terminated by
adding 30 µl of stop mix (250-µg/ml proteinase K, 5 mM EDTA, pH
8.0) and incubation at 60°C for 1 h. Reactions without
deoxynucleoside triphosphate substrates were performed as a control.
Reaction mixtures were boiled for 10 min to inactivate proteinase K
before PCR analysis. A tRNALys-1 primer,
5'-TAGCTCAGTCGGTAGAGCA-3' corresponding to nucleotides 8 to
27 of tRNA1,2Lys was used in a PCR to amplify
minus-strand, strong-stop DNA [(
)ss DNA] linked to
tRNA3Lys; this DNA primer did not amplify
tRNAMet-extended (
)ss DNA or plasmid DNA. To amplify
(
)ss DNA linked to tRNAMet present in the reaction
mixture, a tRNAMet-1 primer was used in a PCR
(5'-GGAATTCGTTAGCGCAGTAGCGCGTCAGTCTCA-3', corresponding to
nucleotides 4 to 35 of tRNAMet); this primer did not
amplify tRNA3Lys-extended (
)ss DNA or plasmid DNA.
Primer 1, corresponding to nucleotides 17 to 38 in the 5' R of HXB2
proviral DNA was used as a 5' PCR primer. A 1-µl volume of the
reaction mixture (equivalent to 100 pg of p24 antigen) was subject to
30 cycles of PCR, each consisting of a denaturing step at 94°C for 1 min, annealing at 60°C for 1 min, and extension at 72°C for 40 s. Amplified products were resolved on a 1.2% agarose gel. To compare
the relative amounts of (
)ss DNA linked to tRNA3Lys
or tRNAMet, Southern hybridization was performed by using
specific probes for tRNA species. The PCR-amplified DNA in the agarose
gel was transferred to a 0.2-µm-pore-size (Protran) nitrocellulose
membrane in 20× SSPE (1× SSPE is 0.18 M NaCl, 10 mM
NaH2PO4, and 1 mM EDTA [pH 7.7]) buffer
(21). DNA was fixed to the membrane by baking at 80°C for
2 h. The probes were the following 32P-end-labeled
tRNA species-specific oligomers: tRNALys-2,
5'-CAGACTTTTAATCTGAGGGTCCAGG-3', corresponding to
nucleotides 28 to 53 of tRNA3Lys;
tRNAMet-2, 5'-CTCATAATCTGAAGGTCGTGAG-3',
corresponding to nucleotides 32 to 53 of tRNAMet.
Prehybridization was carried out at room temperature for 5 to 8 h
in a buffer containing 25% (vol/vol) formamide, 6× SSPE, 0.1% sodium
dodecyl sulfate, 5× Denhardt's solution, and 100-µg/ml yeast tRNA.
Hybridization was initiated by adding the labeled probe to the
prehybridization mixture and continued overnight at room temperature.
The membrane was washed in washing buffer (2× SSPE with 0.1% sodium
dodecyl sulfate) three times for 10 min each at room temperature.
Radioactivity was determined by PhosphorImager analysis of the blots.
Analysis of virus replication.
At 1 day posttransfection,
COS-1 cells were cocultured with SupT1 cells (5 × 105), which support high-level replication of HIV-1. After
48 h of coculture, the SupT1 cells were harvested by low-speed
centrifugation and further cultured with fresh medium and additional
SupT1 cells. The infected SupT1 cells were monitored visually for the
formation of multicell syncytia and maintained by addition of fresh
SupT1 cells and medium at various time intervals. For cell-free
infections at 120 days postcoculture, SupT1 cells (106/ml)
were infected with equal amounts of virus as measured by p24 antigen
(100 ng). After allowing the virus to adsorb for 24 h, SupT1 cells
were further cultured in RPMI medium. At the designated time intervals,
the culture supernatants were collected and analyzed for p24 antigen by
ELISA (Coulter Laboratories).
PCR amplification and DNA sequencing of PBS-containing proviral
DNA.
On designated days postcoculture, DNAs were isolated from
infected SupT1 cells by using the Wizard genomic DNA purification kit
and following the manufacturer's (Promega) instructions. Approximately 1 µg of cellular DNA was used to amplify the U5 and PBS regions of
integrated proviral DNA sequences by using the following HIV-1 proviral-DNA-specific primers: primer 1, 5'-GCTCTAGACCAGATCTGAGCCTGGGAGCTC-3' (nucleotides 17 to 38);
primer 2, 5'-CGGAATTCTCTCCTTCTAGCCTCCGCTAGTC-3' (nucleotides
309 to 330). PCR-amplified DNA was directly ligated into the
pGEM-T-easy vector (Promega). Following transformation into
Escherichia coli and screening, the U5-PBS-containing
plasmid DNAs prepared from individual recombinant clones were sequenced by using the primer 5'-GGCTAACTAGGGAACCCACTGC-3'
(nucleotides 42 to 63).
 |
RESULTS |
Construction of mutant HIV-1 proviral DNAs.
In a previous
study, we demonstrated that the HIV-1 mutants with both a PBS and
nucleotides in U5 complementary to the anticodon loop of
tRNAMet (ACN, the A-loop region in the wild-type genome)
stably maintained a PBS complementary to tRNAMet following
extended in vitro culture; we designated this virus HXB2(Met-AC)
(9). HIV-1 mutants with both a PBS and ACN complementary to
tRNAIle or tRNAPro were not stable and,
following in vitro culture, reverted to contain a wild-type PBS
(8). The results of these studies, combined with those of
others, have led to a greater appreciation of the fact that a complex
RNA structure exists for both the uncomplexed and tRNA-bound U5-PBS
which is important for reverse transcription. A U5-PBS structure for
the wild-type genome has been elucidated from a combination of chemical
and enzymatic analyses (2) (Fig. 1A). Several regions have
been identified which could have importance in the initiation of
reverse transcription. RNA modeling of the U5-PBS revealed a long
stem-loop structure, from nucleotide 159 to nucleotide 186, which
encompasses the initiation site for reverse transcription (nucleotide
182, followed by +1), as well as the ACN (32). Several other
stem-loop structures were also noted (designated a and b in Fig. 1A).
Similar RNA modeling of the genome which stably maintains a PBS
complementary to tRNAMet revealed a structure strikingly
similar to that of the wild type (32). The only major
difference was noted with respect to the nucleotides displayed on the
ACN; in HXB2(Met-AC), the sequence GAGACU was present on the
loop, which is complementary to the nucleotides in the anticodon region
of tRNAMet.
Previous studies by Isel et al. have used both chemical and enzymatic
analyses to determine an HIV-1 tRNA
3Lys binary complex
(Fig.
1B) (
5). Several regions of interaction
between the
viral RNA genome and the tRNA were identified. The
most obvious is the
complementarity between the 3'-terminal nucleotides
of the tRNA and the
PBS (designated I in Fig.
1B). Three additional,
unexpected
interactions between the HIV-1 U5 and tRNA were also
identified
(designated II, III, and IV in Fig.
1B). Again, a similar
binary
complex could also be drawn with the RNA genome of HXB2(Met-AC)
and
tRNA
Met (Fig.
1B).
The conservation of RNA structures between the wild type and
HXB2(Met-AC) suggested their importance for reverse transcription.
To
test this possibility, we targeted mutations to disrupt the
stem-loop
RNA structure of HXB2(Met-AC) (Fig.
1A). The mutations
were selected
for disruption of the predicted U5-PBS RNA structure
but would not be
predicted to disrupt important RNA structures
in the U5-PBS-tRNA
complex (I, II, and IV in Fig.
1B). Thus, we
focused our changes on
nucleotides 153 to 166 in U5 to disrupt
the stem-loop structures in the
regions designated b, c, and d
(Fig.
1A and
2) and constructed
HXB2(Met-AC(157-161)), HXB2(Met-AC(162-164)),
HXB2(Met-AC(157-166)),
and HXB2(Met-AC(153-161)). The nucleotides
were chosen such that the
predicted RNA structures with the mutations
would be sufficiently
different from the original predicted RNA
structure of HXB2(Met-AC) (in
the secondary-structure analysis
using the MFold algorithm). The
mutations were named in accordance
with the following convention:
HXB2(Met-AC(Y-Y)), where Y identifies
the nucleotides changed from the
starting genome, that of HXB2(Met-AC).
We also introduced a second set of mutations into regions III and IV to
disrupt the U5-PBS-tRNA interactions (Fig.
1B and
2), creating HXB2(Met
AC(161-163)), HXB2(Met-AC(143-146)), and
HXB2(Met-AC(143-146,
161-163)); some of these mutations would
also be predicted to disrupt
RNA secondary structures in regions
a and d of Fig.
1A. Finally, we
also constructed a proviral genome
which contained a deletion of the U5
region from nucleotide 142
to nucleotide 173, HXB2(Met-AC(

142-173)).
Although we anticipated
that this virus would be viable since previous
studies by Vicenzi
et al. had demonstrated that deletion of a similar
region in U5
did not result in a noninfectious wild-type virus, we
predicted
that the PBS of this virus would rapidly revert to using
tRNA
3Lys as the primer for reverse transcription
(
26). In addition,
it has previously been reported that
mutations in this region
do not effect encapsidation of the genome RNA
(
26).
Analysis of the infectious potential of mutant proviruses.
The
proviral clones were transfected into 293T cells, and p24 capsid
antigen levels in the culture supernatants were measured at 48 h
posttransfection to determine the effect of mutations on viral protein
production and virion release. The levels of p24 antigen released in
the supernatant were similar in all of the clones tested (data not shown).
To determine the infectious potential of the mutant proviral genomes,
COS-1 cells were transfected with the proviral genomes
and then
cocultured with SupT1 cells, consistent with previous
studies (
9,
20,
28,
29). At various times postcoculture,
the production of
both the wild-type and mutant viruses was monitored
by visual
inspection for syncytia; virus production was also quantitated
by
levels of viral capsid (p24) antigen in the supernatants from
the
cultures (Fig.
3). Although the kinetics
of appearance for
all mutant viruses was delayed compared with
that of HXB2(Met-AC),
the viruses from HXB2(Met-AC(157-166)),
HXB2(Met-AC(153-161)),
HXB2(Met-AC(143-146)), and
HXB2(Met-AC(143-146, 161-163)) showed
the greatest delay.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Appearance of infectious virus after transfection of
mutant proviral genomes. Plasmids containing the wild-type or mutant
proviral genomes were transfected into COS-1 cells and cocultured with
SupT1 cells (5 × 105) 24 h later. After 48 h, the SupT1 cells were isolated by centrifugation, washed once, and
further cultured with additional SupT1 cells and medium (day 0). At
various intervals postcoculture, culture supernatants were collected
and the p24 antigen was quantitated by ELISA. (A) Mutant viruses
designed to affect the secondary structure in the context of RNA alone:
Met-AC(157-161), HXB2(Met-AC(157-161)); Met-AC(162-164),
HXB2(Met-AC(162-164)); Met-AC(157-166), HXB2(Met-AC(157-166));
Met-AC(153-161), HXB2(Met-AC(153-161)); Met-AC, HXB2(Met-AC). (B)
Mutant viruses designed to affect the contacting regions in the complex
of U5-PBS and tRNA: Met-AC(143-145, 161-163), HXB2(Met-AC(143-146,
161-163)); Met-AC(143-146), HXB2(Met-AC(143-146)); Met-AC(161-163),
HXB2(Met-AC(161-163)); Met-AC( 142-173), HXB2(Met-AC-( 142-173)).
|
|
To understand how the mutations in U5 affect viral replication, we
analyzed the initiation of reverse transcription of the
mutant viruses
obtained following transfection of proviral DNA
containing the
designated mutations. For this analysis, we utilized
an in vitro
endogenous RT PCR method to detect (

)ss DNA since
virion particles
contain all of the necessary viral components
for reverse transcription
(
17). The products for endogenous
reverse transcription were
subjected to PCR amplification using
a tRNA-specific primer, followed
by Southern hybridization with
a
32P-labeled tRNA-specific
probe. In preliminary experiments, we
analyzed the wild-type (

)ss DNA
extended from the tRNA
3Lys
[3'R-U5(DNA)-tRNA
3Lys-5']. The amount of (

)ss DNA
increased for approximately 120
min of in vitro incubation time before
plateauing (data not shown).
For the mutants then, we used a 120-min
incubation time for the
reverse transcription reaction and a
tRNA
Met-specific PCR primer with a
tRNA
Met-specific probe complementary to
tRNA
Met to detect (

)ss DNA produced during endogenous
reverse transcription.
The amounts of (

)ss DNA product
[3'R-U5(DNA)-tRNA
Met-5'] were compared for each of the
mutants (Fig.
4A and B). There
was a
general correlation between the amounts of (

)ss DNA detected
and the
appearance of the viruses following transfection. That
is, we detected
lower amounts of the (

)ss DNA product from viruses
derived from
HXB2(Met-AC(157-166)), HXB2(Met-AC(153-161)), HXB2(Met-AC(143-146)),
and HXB2(Met-AC(143-146, 161-163)) than that from HXB2(Met-AC).
The
most severely replication-compromised virus, HXB2(Met-AC-(157-166)),
had the lowest amount of (

)ss DNA product detected from the in
vitro
reactions (Fig.
4A). The correlation was not perfect, however,
as
evidenced by the analysis of HXB2(Met-AC(

142-173). In this
case, we
detected less reverse transcription products from
HXB2(Met-AC(

142-173))
than from other viruses ([e.g.,
HXB2(Met-AC(143-146)). However,
the virus derived from
HXB2(Met-AC(

143-172)) grew faster than
the virus from
HXB2(Met-AC(143-146)). Although the exact reason
for this discrepancy
is not clear, it is possible that the virus
derived from
HXB2(Met-AC(

143-172)) had undergone rapid mutation
as a result of
limited tissue culture, which facilitated virus
replication (see the
next section).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of initiation of reverse transcription. Virus
(equivalent to 6 ng of p24 antigen) produced from transfection of 293T
cells were used in an endogenous reverse transcription reaction (37°C
for 2 h). Endogenous reaction products (equivalent to 100 pg of
p24 antigen) were subjected to 30 cycles of PCR to amplify the extended
tRNAMet linked to ( )ss DNA by using a
tRNAMet-specific primer. No PCR products were observed from
viruses incubated without deoxynucleoside triphosphates (data not
shown). Southern hybridization was used to detect cDNA products of
tRNAMet linked to ( )ss DNA by using a
32P-labeled tRNAMet-specific probe.
Radioactivity was quantified by using a PhosphorImager. (A) Mutant
viruses designed to affect the secondary structure in the context
of RNA alone. Met-AC(157-161), HXB2(MetAC(157-161));
Met-AC(162-164), HXB2(Met-AC(162-164)); Met-AC(157-166),
HXB2(Met-AC(157-166)); Met-AC(153-161), HXB2(Met-AC-(153-161)); Met-AC,
HXB2(Met-AC). (B) Mutant viruses designed to affect the contacting
regions in the binary complex of HIV-1 RNA and tRNA.
Met-AC(143-146,161-163), HXB2(Met-AC-(143-146, 161-163));
Met-AC(143-146), HXB2(Met-AC(143-146)); Met-AC(161-163),
HXB2(Met-AC(161-163)); Met-AC( 142-173), HXB2(Met-AC( 142-173)).
|
|
DNA sequence analysis of the U5-PBS region from integrated
proviruses obtained after extended in vitro culture.
To ascertain
the stability of the PBS in the mutant viruses, after 120 days in
culture we harvested the culture supernatants and analyzed the
replication of the viruses by infecting SupT1 cells with equal amounts
of virus as measured by p24 antigen. Except for strain
HXB2(Met-AC(143-146, 161-163)), all of the mutant viruses replicated
similarly to the wild-type (HXB2) and HXB2(Met-AC) (data not shown);
the replication of HXB2(Met-AC(143-146,161-163)), however, was still
delayed compared to that of the wild-type and mutant viruses.
One of the hallmarks of HIV-1 with a PBS complementary to an
alternative tRNA is the propensity of the PBS to revert to
complementarity
to tRNA
3Lys following in vitro culture.
Previously, we have found that even
subtle mutations within U5 of
viruses with a PBS complementary
to tRNA
His or
tRNA
1,2Lys resulted in reversion back to the wild-type
PBS following in
vitro culture (
30). To determine if this
was also the case for
the mutants with a PBS complementary to
tRNA
Met, we analyzed the U5-PBS from integrated proviruses.
Since the
RT copies the 3' 18 nucleotides of the tRNA used as the
primer
for reverse transcription during positive-strand synthesis, the
proviral PBS sequence reflects which tRNA species was used to
initiate
reverse transcription (
24). Isolation of the
high-molecular-weight
DNAs from the infected cells at 120 days of
culture was followed
by PCR amplification of the U5-PBS region, and the
DNA sequences
of individual subclones were determined (Table
1). Viruses derived
from HXB2(Met-AC),
which have an ACN in U5 to stably utilize tRNA
Met
(
9), maintained the PBS complementary to
tRNA
Met, as expected. Two G-to-A point mutations were found
at nucleotides
140 and 179 upstream of PBS in most clones; these
mutations result
in an A-U instead of a G-U base pair in the stem-loop
structure
of Fig.
1A. Interestingly, a few clones (two of nine) were
obtained
which contain two PBSs complementary to tRNA
Met
with additional nucleotides consistent with a duplication of
the 13 nucleotides downstream of PBS and the 12 nucleotides upstream
of PBS.
Sequence analysis of the proviral PBS from viruses
HXB2(Met-AC(157-161)), HXB2(Met-AC(153-161)), and HXB2(Met-AC(161-163))
revealed that all maintained a PBS complementary to
tRNA
Met, although we did not recover the starting proviral
sequence in
any of the clones analyzed. Most of the nucleotide changes
were
one- or two-base changes consisting mainly of a G-to-A change
(data not shown). Analysis of the proviral clones of the U5-PBS
from
viruses derived from HXB2(Met-AC(143-146)) revealed that
all of the
clones contained a deletion of nucleotides 135 to 141
with a change of
nucleotides 143 to 146 (GGAA to CCCT). This reversion
would restore the
wild-type sequence for this virus similar to
that found in HXB2(Met-AC)
(CCUU versus CCCU). RNA modeling suggests
that the CCUU sequence is
critical for the interaction of the
U5-PBS with tRNA
Met.
Analysis of the U5-PBS from several of the viruses revealed many times
two distinct PBSs complementary to tRNA
Met. For example,
the virus derived from HXB2(Met-AC(162-164)) in
four of six clones
contained an insertion of a 68-nucleotide sequence
which is composed of
34 nucleotides upstream, an 18-nucleotide
sequence complementary to
tRNA
Met, and 16 nucleotides downstream; all of these
inserted nucleotide
sequences were duplicated from the sequence
upstream or downstream
of the PBS. All of the clones recovered from
HXB2(Met-AC(143-146,
161-163)) at day 120 contained dual PBSs; the
upstream PBS was
complementary to tRNA
Met, and most
importantly, the downstream PBS was a wild-type PBS
complementary to
tRNA
3Lys. A two-nucleotide deletion immediately
downstream of the wild-type
PBS suggested that a mismatch repair might
have occurred during
the second template switch in which a
tRNA
3Lys was positioned at the PBS complementary to
tRNA
Met. In a previous study, we have shown that both of
the PBSs from
viruses with dual PBSs can be utilized for initiation of
reverse
transcription (
12,
13). It is possible, then, that
the virus
derived from HXB2(Met-AC(143-146, 161-163)) grows slower than
the other mutant viruses because of interference between two different
PBSs for reverse transcription. All of the clones recovered from
the
virus derived from HXB2(Met-AC(157-166)), with mutations encompassing
the stem region of the stem-loop structure upstream of the PBS,
contained a wild-type PBS complementary to tRNA
3Lys at
day 120 with eight nucleotides duplicated from the sequence
upstream of
PBS (Table
1). Half of the clones examined also contained
additional
insertions of a PBS complementary to tRNA
Met and 27 duplicated nucleotides (14 nucleotides upstream and 13
downstream of
PBS). Again, mutations predicted to completely disrupt
the stem-loop
structure in U5 upstream of PBS resulted in viruses
reverting to
contain a PBS complementary to tRNA
3Lys.
A completely unexpected result was obtained from the analysis of the
virus derived from HXB2(Met-AC(

142-173)), which contained
a
32-nucleotide deletion in U5 (Fig.
2). Upon extended in vitro
culture,
we found that this virus still stably maintained a PBS
complementary to
tRNA
Met. All of the clones recovered, however, had an
additional 19 nucleotides
inserted upstream of the PBS; 15 of these
nucleotides were duplicated
from nucleotides immediately upstream of
the PBS of the input
proviral genome. This is the first time that we
have obtained
viruses which contain a substantial change in U5 that
were still
able to maintain the use of an alternative tRNA as a primer
for
initiation of reverse
transcription.
 |
DISCUSSION |
In this study, we have utilized a unique HIV-1 strain which stably
maintains a PBS complementary to tRNAMet to characterize
U5-PBS interactions with the tRNA primer used for initiation of reverse
transcription. RNA modeling of the U5-PBS alone and complexed with
tRNAMet revealed striking similarities to models of the
wild-type U5-PBS alone and complexed with tRNA3Lys. To
investigate the potential significance of these RNA structures, we
constructed mutations designed to disrupt critical elements within the
secondary structures. All of the mutations resulted in viruses which
initially had delayed replication compared to the parental virus,
HXB2(Met-AC). By using an endogenous reverse transcription-PCR method,
we found that the delays in replication correlated with a reduced
capacity for initiation of reverse transcription as determined by the
ability to synthesize (
)ss DNA primed with tRNAMet.
Analysis of the U5-PBS following long-term in vitro culture revealed
that while most mutants were stable and maintained a PBS complementary
to tRNAMet, others had reverted to a virus with a PBS
complementary to tRNA3Lys. In some instances, viruses
with complex genomes containing dual PBSs were observed. Interestingly,
we found that viruses which initially contained a deletion of 32 nucleotides of the U5 region still maintained a PBS complementary to
tRNAMet following in vitro culture. Sequence analysis of
the U5-PBS of this virus revealed the presence of 19 new nucleotides in
place of the original deletion.
In previous reports, we have described the effects that mutations in U5
have on the subsequent capacity of HIV-1 to stably utilize
tRNAHis or tRNA1,2Lys to initiate reverse
transcription (9, 10, 29, 30, 31). Mutations within the U5
region of these viruses all had drastic effects on the subsequent
capacity to maintain a PBS complementary to these alternative tRNAs
(30). One of the major differences between the virus which
utilizes tRNAMet to initiate reverse transcription and the
other viruses which use other tRNAs to initiate reverse transcription
is the ability of HXB2(Met-AC) to accommodate several different types
of mutations within U5 without reverting to a PBS complementary to
tRNA3Lys. It is possible that this feature is due to
the fact that RNA structures of the U5-PBS of HXB2(Met-AC) alone and
complexed with tRNAMet are similar to that of the wild-type
virus and, thus, stabilize the use of tRNAMet to initiate
reverse transcription. Several of the results from our analysis of
different virus mutants support this idea. Analysis of the virus
derived from HXB2(Met-AC-(143-146)) revealed that all of the clones had
restored the CCCT nucleotides which could potentially interact with the
variable loop of tRNAMet (region IV in Fig. 1B). Previous
studies in our laboratory have shown that even in the wild-type genome,
mutation in this region resulted in a virus which reverts to restore
the CCCT motif (31). What is the importance of this
interaction? One explanation could be that this interaction is required
to maintain the disrupted tRNA structure necessary to form an
initiation complex similar to what has been found by Isel et al.
(5) (Fig. 1B). However, the CCCT reversion would not be
predicted to completely restore the region IV interaction in
HXB2(Met-AC(142-146)). Thus, it is possible that this motif is involved
in other, as yet undefined, RNA-RNA interactions within the viral
genome that result in additional selective pressure for the reversion
to CCCT. The further analysis of the role of the CCCT motif in reverse
transcription might be complicated because we found that in contrast to
strain HXB2(Met-AC(143-166)), double mutant HXB2(Met-AC(143-146,
161-163)) did not contain this reversion following in vitro culture.
Rather, this virus had mutated to contain a PBS complementary to
tRNA3Lys positioned downstream from the PBS
complementary to tRNAMet. In a related set of experiments,
we found that the wild-type virus containing a similar set of mutations
also did not restore the CCCT motif (31). Why the virus
derived from HXB2(Met-AC(143-146, 161-163) mutated to contain two PBSs
is not clear. Virus HXB2(Met-AC(143-146,161-163)) maintained a
slow-growth phenotype, even after extended culture (data not shown). It
is possible that the positioning of a PBS complementary to
tRNA3Lys downstream from the PBS complementary to
tRNAMet interfered with the reverse transcription process.
Previous studies in this laboratory have shown that if the upstream PBS
in mutant viral genomes with dual PBSs was complementary to
tRNA3Lys, this PBS was used predominantly for reverse
transcription (12). Furthermore, viruses with this dual-PBS
configuration did not show a delay in replication compared to the
wild-type virus; this result was similar to what was found for
HXB2(Met-AC(157-166)), in which a PBS complementary to
tRNA3Lys is positioned upstream of a PBS complementary
to tRNAMet. In contrast, the viruses derived from
HXB2(Met-AC(143-146, 161-163)) contain an upstream PBS complementary to
tRNAMet positioned in front of a PBS complementary to
tRNA3Lys. The combination of both PBSs occupied by
tRNAMet and tRNA3Lys, respectively, could
affect the capacity of the virus to undergo reverse transcription
(12, 13).
One of the hallmarks of the viruses with a PBS complementary to an
alternative tRNA is the generation of numerous nucleotide changes in U5
following in vitro replication. Based on the results of our previous
studies, we suggested that these mutations might be the result of
selection of viruses which can undergo a more efficient initiation of
reverse transcription (27). The results of our current study
also support this idea. It was clear from our analysis of the mutant
viruses constructed from HXB2(Met-AC) that mutations in the U5 region
affected reverse transcription. Not surprisingly, those viruses derived
from HXB2(Met-AC(157-166)), in which the mutants most severely affected
the initiation of reverse transcription, also exhibited the slowest
initial replication. Similar results have been obtained from analysis
of the wild-type virus with mutations in U5 (31). Deletion
of the four consecutive A's in the U5 stem-loop of HIV-1 did not
affect tRNA3Lys placement on the genomic RNA; however,
viruses with the deleted A nucleotides exhibited decreased reverse
transcription and slower replication kinetics (6, 14). What
was most interesting, however, was that the A loop was restored over
time during in vitro culture (14). Analysis of the U5 region
from the virus derived from HXB2(Met-AC(153-161)) revealed a similar
situation after in vitro culture. Modeling of the RNA stem-loop of the
U5-PBS from nucleotide 126 to nucleotide 222 revealed that the initial mutations would have resulted in a stem-loop structure containing different nucleotides in the region postulated to interact with the
anticodon loop of tRNAMet (Fig.
5). RNA modeling of the U5 of viruses
obtained after in vitro culture revealed an apparent evolution toward
recovery of the stem-loop structure seen for the U5 derived from
HXB2(Met-AC). Most importantly, the region of U5 complementary to the
anticodon of tRNAMet can be displayed on the loop region of
a stem-loop structure similar to that for HXB2(Met-AC). In contrast to
HXB2(Met-AC(153-161)), viruses derived from HXB2(Met-AC(157-166)), with
mutations predicted to completely disrupt this stem-loop structure,
displayed a greater defect in initiation of reverse transcription and
eventually reverted to contain the wild-type PBS. Why then do some
mutations lead to reversion of the PBS to complementarity to
tRNA3Lys? One possibility is that mutations that
disrupt the U5-PBS structure result in an RNA genome encapsidated in
the virus without a tRNA positioned at the PBS complementary to an
alternative tRNA. If this were to happen, upon maturation of the virus
particle, the nucleocapsid protein (p7) and/or RT might force
tRNA3Lys to be positioned at the PBS complementary to
the alternative tRNA. If initiation of reverse transcription occurred,
the virus would have a potential for two PBSs, one complementary to
tRNAMet (for negative-strand DNA) and one complementary to
tRNA3Lys (for positive-strand DNA), which would lead to
viruses with dual PBSs. Further replication of these viruses might lead
to a stable virus with dual PBSs (which was observed) or even
resolution of the dual PBSs to a single wild-type PBS complementary to
tRNA3Lys (12).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Effects of additional mutations on recovery of the RNA
stem-loop structure upstream of PBS in viruses derived from
HXB2(Met-AC(153-161)). The secondary structures of RNA encompassing
nucleotides 126 to 222 with input mutations and with additional
mutations following in vitro culture were predicted by using the RNA
folding algorithm MFold (32, 33). Only the nucleotides (153 to 191) forming a stem-loop structure upstream of PBS are shown. The
input mutations between nucleotides 153 and 161 are in the rectangle.
Individual mutations following in vitro culture are in lowercase and
boxed.
|
|
Finally, compelling evidence for a general role of RNA structures in
the selection of the tRNA and reverse transcription comes from the
analysis of the virus which contained a 32-nucleotide deletion in U5.
Remarkably, this virus was still able to undergo reverse transcription
and exhibited replication kinetics similar to that of the parental
virus. Molecular modeling of the RNA structures of the virus containing
the additional 19-nucleotide insertion revealed a similar overall
structure for the U5-PBS genome alone (Fig.
6), as well as in the presence of
tRNAMet (Fig. 7). The
additional 19 nucleotides in the virus derived from
HXB2(Met-AC-(
142-173)) were essential to restore similar stem-loop
RNA structures modeled from HXB2(Met-AC) (Fig. 1A). The additional
nucleotides would also be predicted to restore the interaction at
region IV of the U5-PBS complexed with tRNAMet (Fig. 7).
Taken together, the results of our study support the concept that RNA
structures of the U5-PBS are important for the interaction with the
tRNA used for initiation of reverse transcription.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 6.
Additional mutations in U5 restore the secondary
structures of RNA alone in viruses derived from
HXB2(Met-AC( 142-173)). Dots shows deleted nucleotides 142 to 173 in
the context of secondary structure of HXB2(Met-AC). The secondary
structure with input deletion mutations and with the additional
mutation of a 19-nucleotide insertion was predicted by the MFold RNA
folding algorithm (32, 33). Inserted nucleotides are in
boldface lowercase letters with line drawing. Boxed nucleotide 182 indicates a point mutation.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 7.
Additional mutations in U5 restore the secondary
structure of RNA complexed with tRNAMet. The models of
viral RNA secondary structure complexed with tRNAMet were
predicted in the viruses derived from HXB2(Met-AC( 142-173)). tRNA
sequences are in boldface lowercase letters. 32 indicates a
32-nucleotide deletion between nucleotides 141 and 174. (A) Input
mutant showing enough complementary nucleotide interactions in regions
II and III in U5. (B) Additional mutations caused by inserting 19 nucleotides upstream of PBS following culture, allowing formation of
the secondary structure of viral RNA complexed with tRNAMet
more like HXB2(Met-AC), restoring the important interaction in region
IV, as shown in the box (Fig. 1B). The insertion of 19 nucleotides
between nucleotides 135 and 136 is in shadowed uppercase letters.
|
|
 |
ACKNOWLEDGMENTS |
We thank Zhijun Zhang and Qin Yu for helpful comments and Dee
Martin for preparation of the manuscript. C.D.M. thanks MAR for
continued support.
Virus culture was carried out in the UAB AIDS Center Virus Culture Core
(AI 27767). This work was supported by grants AI-34749 and GM 56544 to
C.D.M.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, University of Alabama at Birmingham, Birmingham, AL
35294. Phone: (205) 934-5705. Fax: (205) 934-1580. E-mail:
casey_morrow{at}micro.micobio.uab.edu.
 |
REFERENCES |
| 1.
|
Baltimore, D.
1970.
Viral RNA-dependent DNA polymerase.
Nature (London)
226:1209-1211[Medline].
|
| 2.
|
Baudin, F.,
R. Marquet,
C. Isel,
J.-L. Darlix,
B. Ehresmann, and C. Ehresmann.
1992.
Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.
J. Mol. Biol.
229:382-397.
|
| 3.
|
Das, A. T.,
B. Klaver, and B. Berkhout.
1995.
Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primer other than the natural tRNA3Lys.
J. Virol.
69:3090-3097[Abstract].
|
| 4.
|
Gilboa, E.,
S. W. Mitra,
S. Goff, and D. Baltimore.
1979.
A detailed model of reverse transcription and tests of crucial aspects.
Cell
18:93-100[Medline].
|
| 5.
|
Isel, C.,
C. Ehresmann,
G. Keith,
B. Ehresmann, and R. Marquet.
1995.
Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNALys,3 (template/primer) complex.
J. Mol. Biol.
247:236-250[Medline].
|
| 6.
|
Isel, C.,
J.-M. Lanchy,
S. F. J. L. Grice,
C. Ehresmann,
B. Ehresmann, and R. Marquet.
1996.
Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNALys,3.
EMBO J.
15:917-924[Medline].
|
| 7.
|
Jiang, M.,
J. Mak,
A. Ladha,
E. Cohen,
M. Klein,
B. Rovinski, and L. Kleiman.
1993.
Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.
J. Virol.
67:3246-3253[Abstract/Free Full Text].
|
| 8.
|
Kang, S.-M.,
J. K. Wakefield, and C. D. Morrow.
1996.
Mutations in both the U5 region and primer binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
Virology
222:401-414[Medline].
|
| 9.
|
Kang, S.-M.,
Z. Zhang, and C. D. Morrow.
1997.
Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNAMet.
J. Virol.
71:207-217[Abstract].
|
| 10.
| Kang, S.-M., Z. Zhang, and C. D. Morrow. Identification of a human immunodeficiency virus type 1 which stably uses tRNA1,2Lys rather than
tRNA3Lys for initiation of reverse transcription.
Submitted for publication.
|
| 11.
|
Li, X.,
M. Johnson,
E. J. Arts,
Z. Gu,
L. Kleiman,
M. A. Wainberg, and M. A. Parniak.
1994.
Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.
J. Virol.
68:6198-6206[Abstract/Free Full Text].
|
| 12.
|
Li, Y.,
S.-M. Kang, and C. D. Morrow.
1997.
Stability of HIV-1 proviral genomes which contain two distinct primer binding sites.
AIDS Res. Hum. Retroviruses
13:253-262[Medline].
|
| 13.
|
Li, Y.,
Z. Zhang,
S.-M. Kang,
J. L. Buescher, and C. D. Morrow.
1997.
Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNAGly and tRNAHis.
Virology
238:273-282[Medline].
|
| 14.
|
Liang, C.,
X. Li,
L. Rong,
P. Inouye,
Y. Quan,
L. Kleiman, and M. A. Wainberg.
1997.
The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity.
J. Virol.
71:5750-5757[Abstract].
|
| 15.
|
Mak, J., and L. Kleiman.
1997.
Primer tRNAs for reverse transcription.
J. Virol.
71:8087-8095[Medline].
|
| 16.
|
Marquet, R.,
C. Isel,
C. Ehreshmann, and B. Ehreshmann.
1995.
tRNA as primer of reverse transcriptase.
Biochimie
77:113-124[Medline].
|
| 17.
|
Masuda, T.,
V. Planelles,
P. Krogstad, and I. S. Y. Chen.
1995.
Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
J. Virol.
69:6687-6696[Abstract].
|
| 18.
|
Peters, G., and J. E. Dahlberg.
1979.
RNA-directed DNA synthesis in the Moloney murine leukemia virus: interaction between the primer tRNA and the genome.
J. Virol.
31:398-407[Abstract/Free Full Text].
|
| 19.
|
Ratner, L.,
A. Fisher,
L. Linda,
J. Agodzinski,
H. Mitsuya,
R.-S. Liou,
R. C. Gallo, and F. Wong-Staal.
1987.
Complete nucleotide sequences of functional clones of the AIDS virus.
AIDS Res. Hum. Retroviruses
3:57-69[Medline].
|
| 20.
|
Rhim, H.,
J. Park, and C. D. Morrow.
1991.
Deletions in the tRNALys primer binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription.
J. Virol.
65:4555-4564[Abstract/Free Full Text].
|
| 21.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 22.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 23.
|
Sarker, G., and S. S. Wimmer.
1990.
The "megaprimer" method of site-directed mutagenesis.
BioTechniques
8:404-407[Medline].
|
| 24.
|
Taylor, J. M., and T. W. Hsu.
1980.
Reverse transcription of avian sarcoma virus RNA into DNA might involve copying of the tRNA primer.
J. Virol.
33:531-534[Abstract/Free Full Text].
|
| 25.
|
Temin, H. M., and S. Mizutani.
1970.
RNA-directed DNA polymerase in virions of Rous sarcoma virus.
Nature
226:1211-1213[Medline].
|
| 26.
|
Vicenzi, E. D.,
S. Dimitro,
A. Engleman,
T. Migone,
D. F. J. Purcell,
J. Leonard,
G. Englund, and M. A. Martin.
1994.
An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.
J. Virol.
68:7879-7890[Abstract/Free Full Text].
|
| 27.
|
Wakefield, J. K.,
S.-M. Kang, and C. D. Morrow.
1996.
Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNAHis.
J. Virol.
70:966-975[Abstract].
|
| 28.
|
Wakefield, J. K.,
A. G. Wolf, and C. D. Morrow.
1995.
Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNALys,3.
J. Virol.
69:6021-6029[Abstract].
|
| 29.
|
Zhang, Z.,
S.-M. Kang,
A. LeBlanc,
S. L. Hajduk, and C. D. Morrow.
1996.
Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for a human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNAHis.
Virology
226:306-317[Medline].
|
| 30.
|
Zhang, Z.,
S.-M. Kang,
Y. Li, and C. D. Morrow.
1998.
Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription.
RNA
4:394-406[Abstract].
|
| 31.
|
Zhang, Z.,
S.-M. Kang, and C. D. Morrow.
1998.
Genetic evidence for the interaction between tRNALys,3 and U5 facilitating efficient initiation of reverse transcription by human immunodeficiency type 1.
AIDS Res. Hum. Retroviruses
14:979-988[Medline].
|
| 32.
|
Zuker, M.
1989.
On finding all suboptimal foldings of an RNA.
Science
244:48-52[Abstract/Free Full Text].
|
| 33.
|
Zuker, M., and P. Stiegler.
1981.
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information.
Nucleic Acids Res.
9:133-148[Abstract/Free Full Text].
|
Journal of Virology, March 1999, p. 1818-1827, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Palmer, M. T., Kirkman, R., Kosloff, B. R., Eipers, P. G., Morrow, C. D.
(2007). tRNA Isoacceptor Preference prior to Retrovirus Gag-Pol Junction Links Primer Selection and Viral Translation. J. Virol.
81: 4397-4404
[Abstract]
[Full Text]
-
Marozsan, A. J., Fraundorf, E., Abraha, A., Baird, H., Moore, D., Troyer, R., Nankja, I., Arts, E. J.
(2004). Relationships between Infectious Titer, Capsid Protein Levels, and Reverse Transcriptase Activities of Diverse Human Immunodeficiency Virus Type 1 Isolates. J. Virol.
78: 11130-11141
[Abstract]
[Full Text]
-
Abbink, T. E. M., Beerens, N., Berkhout, B.
(2004). Forced Selection of a Human Immunodeficiency Virus Type 1 Variant That Uses a Non-Self tRNA Primer for Reverse Transcription: Involvement of Viral RNA Sequences and the Reverse Transcriptase Enzyme. J. Virol.
78: 10706-10714
[Abstract]
[Full Text]
-
Miller, J. T., Khvorova, A., Scaringe, S. A., Le Grice, S. F. J.
(2004). Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes. Nucleic Acids Res
32: 4687-4695
[Abstract]
[Full Text]
-
Rigourd, M., Goldschmidt, V., Brule, F., Morrow, C. D., Ehresmann, B., Ehresmann, C., Marquet, R.
(2003). Structure-function relationships of the initiation complex of HIV-1 reverse transcription: the case of mutant viruses using tRNAHis as primer. Nucleic Acids Res
31: 5764-5775
[Abstract]
[Full Text]
-
Dupuy, L. C., Kelly, N. J., Elgavish, T. E., Harvey, S. C., Morrow, C. D.
(2003). Probing the Importance of tRNA Anticodon: Human Immunodeficiency Virus Type 1 (HIV-1) RNA Genome Complementarity with an HIV-1 That Selects tRNAGlu for Replication. J. Virol.
77: 8756-8764
[Abstract]
[Full Text]
-
Sakuragi, J.-I., Ueda, S., Iwamoto, A., Shioda, T.
(2003). Possible Role of Dimerization in Human Immunodeficiency Virus Type 1 Genome RNA Packaging. J. Virol.
77: 4060-4069
[Abstract]
[Full Text]
-
Kvaratskhelia, M., Miller, J. T., Budihas, S. R., Pannell, L. K., Le Grice, S. F. J.
(2002). Identification of specific HIV-1 reverse transcriptase contacts to the viral RNA:tRNA complex by mass spectrometry and a primary amine selective reagent. Proc. Natl. Acad. Sci. USA
99: 15988-15993
[Abstract]
[Full Text]
-
Goldschmidt, V., Rigourd, M., Ehresmann, C., Le Grice, S. F. J., Ehresmann, B., Marquet, R.
(2002). Direct and Indirect Contributions of RNA Secondary Structure Elements to the Initiation of HIV-1 Reverse Transcription. J. Biol. Chem.
277: 43233-43242
[Abstract]
[Full Text]
-
Gabor, J., Cen, S., Javanbakht, H., Niu, M., Kleiman, L.
(2002). Effect of Altering the tRNAConcentration in Human Immunodeficiency Virus Type 1 upon Its Annealing to Viral RNA, GagPol Incorporation, and Viral Infectivity. J. Virol.
76: 9096-9102
[Abstract]
[Full Text]
-
Kameoka, M., Morgan, M., Binette, M., Russell, R. S., Rong, L., Guo, X., Mouland, A., Kleiman, L., Liang, C., Wainberg, M. A.
(2002). The Tat Protein of Human Immunodeficiency Virus Type 1 (HIV-1) Can Promote Placement of tRNA Primer onto Viral RNA and Suppress Later DNA Polymerization in HIV-1 Reverse Transcription. J. Virol.
76: 3637-3645
[Abstract]
[Full Text]
-
Rong, L., Liang, C., Hsu, M., Guo, X., Roques, B. P., Wainberg, M. A.
(2001). HIV-1 Nucleocapsid Protein and the Secondary Structure of the Binary Complex Formed between tRNALys.3 and Viral RNA Template Play Different Roles during Initiation of (-) Strand DNA Reverse Transcription. J. Biol. Chem.
276: 47725-47732
[Abstract]
[Full Text]
-
Yu, Q., Morrow, C. D.
(2000). Essential regions of the tRNA primer required for HIV-1 infectivity. Nucleic Acids Res
28: 4783-4789
[Abstract]
[Full Text]
-
Wei, X., Gotte, M., Wainberg, M. A.
(2000). Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers. Nucleic Acids Res
28: 3065-3074
[Abstract]
[Full Text]
-
Brown, H. E. V., Chen, H., Engelman, A.
(1999). Structure-Based Mutagenesis of the Human Immunodeficiency Virus Type 1 DNA Attachment Site: Effects on Integration and cDNA Synthesis. J. Virol.
73: 9011-9020
[Abstract]
[Full Text]
-
Miller, J. T., Ehresmann, B., Hubscher, U., Le Grice, S. F. J.
(2001). A Novel Interaction of tRNALys,3 with the Feline Immunodeficiency Virus RNA Genome Governs Initiation of Minus Strand DNA Synthesis. J. Biol. Chem.
276: 27721-27730
[Abstract]
[Full Text]